Secondary stroke prevention: Practice patterns in a tertiary care stroke service

Canadian Journal of Neurological Sciences

Volumn 37, Issue 2, 2010, Pages 245-251

  Fan, Janice ^a   Mysak, Tania ^b   Jeerakathil, Thomas ^c   Pearson, Glen ^c  

^a NORTH YORK GENERAL HOSPITAL   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; DIZZINESS; FEMALE; HEADACHE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HOSPITAL SERVICE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SMOKING CESSATION; STROKE; TERTIARY HEALTH CARE; TRANSIENT ISCHEMIC ATTACK;

EID: 76649105780     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100010003     Document Type: Article

References (36)

1. Stroke statistics. Ottawa (ON): Heart and Stroke Foundation of Canada; [no date, cited April 10th, 2008]. Available from: http://www.heartandstroke.ab. ca/site/c.lqIRL1PJJtH/b.3651251/ k.BD66/stroke-statistics.htm.
2. Canadian Institute for Health Information. The burden of neurological diseases, disorders and injuries in Canada. Ottawa (ON): CIHI; 2007.
3. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326.
4. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, et al. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke. 2002;33:901-906
5. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
6. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
7. The ESPRIT Study Group.Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-1673
8. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339
9. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337
10. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262
11. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 2004;126(3)Suppl:S483S-512.
12. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for the prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577-617.
13. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041
14. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-2749
15. Semplicini A, Calo L. Administering antihypertensive drugs after acute ischemic stroke: timing is everything. CMAJ. 2005;172(5): 625-626
16. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998; 339(19):1349-1357
17. Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. Circulation. 1999;99:216-223
18. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355 (6):549-559
19. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326: 1423-1427
20. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective metaanalysis of data from 90056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278
21. Graham ID, Beardall S, Carter AO, Glennie J, Hebert PC, Tetroe JM, et al. What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ. 2001;165(2):157-163
22. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282: 1458-1465
23. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al. Get With the Guidelines Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009; 119:107-115
24. Kapral MK, Laupacis A, Phillips SJ, Silver FL, Hill MD, Fang J, et al. Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network. Stroke. 2004;35: 1756-1762
25. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke. 2002;33:1656-1659
26. Mouradian MS, Hussain MS, Lari H, Salam A, Senthilselvan A, Dean N, et al. The impact of a stroke prevention clinic in diagnosing modifiable risk factors for stroke. Can J Neurol Sci. 2005;32:496-500.
27. Capital Health programs and services: acute stroke. Edmonton (AB): Capital Health; [no date, cited December 15th, 2006]. Available from: www.capitalhealth.ca/ProgramsAndServices/ BrowseServicesByAlpha/Content?IA-ID// 5988.
28. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, enhanced Canadian version (ICD-10-CA). Ottawa (ON): Canadian Institute of Health Information; [no date; cited January 5th, 2007]. Available from: http://secure.cihi.ca/cihiweb/dispPage.jsp?cw-page//codingclass -icd10-e.
29. Research Randomizer. Middletown (CT): Urbaniak GC, Plous S; [no date; cited March 4th, 2007]. Available from: www.randomizer.org/form.htm.
30. Canadian Hypertension Education Program recommendations for the management of hypertension 2006. Ottawa (ON): Canadian Hypertension Education Program; [no date, cited October 25th, 2006]. Available from: www.hypertension.ca.
31. Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ. 2003;169(9):921-924
32. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647-1652
33. Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebocontrolled study. Lancet Neurol. 2008;7:875-884
34. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New Engl J Med. 2004;350: 1495-1504
35. California Acute Stroke Pilot Registry (CASPR) Investigators. The impact of standardized stroke orders on adherence to best practices. Neurology. 2005;65:360-365
36. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, McNair N, Dandekar A, et al. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology. 2004;63: 1217-1222